financetom
Business
financetom
/
Business
/
CrowdStrike Seen Sustaining Annual Recurring Revenue Growth, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CrowdStrike Seen Sustaining Annual Recurring Revenue Growth, Oppenheimer Says
Aug 28, 2025 8:02 AM

10:33 AM EDT, 08/28/2025 (MT Newswires) -- CrowdStrike ( CRWD ) is seen sustaining the 20% annual recurring revenue growth it posted in fiscal Q2, Oppenheimer said in a Wednesday note.

The brokerage noted that module adoption dynamics are normalizing after the termination of the customer commitment package program and Falcon Flex contract utilization continues to be high.

Net new annual recurring revenue is increasing substantially due to solid growth in next-gen products, Oppenheimer said.

The firm said that for fiscal Q2, net new annual recurring revenue of about $221 million topped the consensus of roughly $202 million and went back to year-over-year growth a quarter earlier than what management had expected.

Oppenheimer maintained the company's outperform rating and $520 price target.

Price: 431.65, Change: +9.04, Percent Change: +2.14

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eupraxia Prices US$70M Share Offering at $5.50; U.S.-Listed Shares Fall 13% Pre-Market
Eupraxia Prices US$70M Share Offering at $5.50; U.S.-Listed Shares Fall 13% Pre-Market
Sep 23, 2025
07:14 AM EDT, 09/23/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) overnight Monday, priced its previously announced public offering for about US$70 million, before deducting commissions and estimated expenses, taking its U.S.-listed shares down 13%, pre-market. The company issued 12.7-million common shares at $5.50 apiece as part of the offering. It also granted the underwriters a 30-day option to...
Market Chatter: Boeing Offers Remedies to EU in Bid to Gain Approval for Spirit AeroSystems Buyout
Market Chatter: Boeing Offers Remedies to EU in Bid to Gain Approval for Spirit AeroSystems Buyout
Sep 23, 2025
07:14 AM EDT, 09/23/2025 (MT Newswires) -- Boeing ( BA ) has proposed concessions to the EU to gain approval for its $4.7 billion purchase of Spirit AeroSystems ( SPR ) , Reuters reported Tuesday, citing an update on the European Commission website. The Commission has extended its review deadline to Oct. 14 and will likely seek industry feedback before...
Aescape Acquires Exclusive Rights to Tom Brady's Science-Backed Longevity Protocols, Adds Brady and Alex Spiro as Strategic Partners
Aescape Acquires Exclusive Rights to Tom Brady's Science-Backed Longevity Protocols, Adds Brady and Alex Spiro as Strategic Partners
Sep 23, 2025
NEW YORK, Sept. 23, 2025 /PRNewswire/ -- Aescape, the leader in AI-powered recovery technology, today announced it has acquired the exclusive rights to Tom Brady's recovery and longevity protocols, marking a major milestone in the company's mission to deliver pro-level wellness to the broader public. As part of the partnership, Tom Brady joins Aescape as its Chief Innovation Officer, together with...
TD to Redeem $200M Series 9 Preferred Shares on Oct. 31, Final Dividend Set
TD to Redeem $200M Series 9 Preferred Shares on Oct. 31, Final Dividend Set
Sep 23, 2025
07:17 AM EDT, 09/23/2025 (MT Newswires) -- The Toronto-Dominion Bank ( MLWIQXX ) (TD.TO, TD) overnight Monday said that it will redeem all of its 8 million outstanding Non-Cumulative 5-Year Rate Reset Class A First Preferred Shares, Series 9 on Oct. 31, at $25 each for an aggregate total of approximately $200 million. The redemption was approved by the Office...
Copyright 2023-2026 - www.financetom.com All Rights Reserved